CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.

BMC Cancer · 2011 · PMC3196967 · PMID 21957977

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significanceP = 0.051so close (0.05 < p ≤ 0.1)

Specifically, CD44v2-v10 expression was significantly higher in luminal A compared to the basal-like (P = 0.0001), luminal B (P = 0.038), normal-like (P = 0.011) and HER2-enriched subtype (borderline significance; P = 0.051).

also in 4,327 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.